Sign in

CIK 0001652130 · Large accelerated filer

Intellia Therapeutics, Inc.

Sign in to watch
Ticker
NTLA
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364785571
Phone
857-285-6200
Business address
400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
  1. 8-K Event Regulation FD disclosure · Other events
  2. 4 Grant or award Director acquired 9,200 shares (grant or award)
  3. 4 Grant or award Director acquired 9,200 shares (grant or award)
  4. 4 Grant or award Director acquired 9,200 shares (grant or award)
  5. 4 Grant or award Director acquired 9,200 shares (grant or award)
  6. 4 Grant or award Director acquired 9,200 shares (grant or award)
  7. 4 Grant or award Director acquired 9,200 shares (grant or award)
  8. 4 Grant or award Director acquired 9,200 shares (grant or award)
  9. 8-K Event Shareholder vote results
  10. 10-Q Report Quarterly Report
  11. 8-K Event Results of operations
  12. 8-K Event Material agreement · Results of operations
  13. ARS Other Annual Report to Security Holders
  14. DEFA14A Proxy Proxy Materials
  15. DEF 14A Proxy Proxy Statement
  16. SCHEDULE 13G Stake Statement of Beneficial Ownership
  17. 424B5 Offering Prospectus
  18. SCHEDULE 13G Stake Statement of Beneficial Ownership
  19. 424B5 Offering Prospectus
  20. 8-K Event Regulation FD disclosure · Other events

Page 2 of 37 · 724 filings